Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Tiberghien

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Chemical Communications (Cambridge, England)|August 29, 2002
Synthesis of novel C2-aryl pyrrolobenzodiazepines (PBDs) as potential antitumour agentsNectaroula Cooper, David R Hagan, Arnaud Tiberghien, et al.
Chemical Communications (Cambridge, England)|February 1, 2023
Peroxide-cleavable linkers for antibody-drug conjugatesNicola Ashman, Jonathan D Bargh, Stephen J Walsh, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 4, 2026
Bismuth BicyclesSaan Voss, Amin Sagar, Arnaud Tiberghien, et al.
Bioconjugate Chemistry|March 27, 2019
Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life ExtensionQing Li, Allison Barrett, Balakumar Vijayakrishnan, et al.
Blood|January 5, 2018
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignanciesFrancesca Zammarchi, Simon Corbett, Lauren Adams, et al.
Journal of Medicinal Chemistry|September 1, 2006
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugatesGeoff Wells, Christopher R H Martin, Philip W Howard, et al.
Plos Neglected Tropical Diseases|May 24, 2019
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasisPaula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, et al.
Scientific Reports|July 12, 2018
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirineJohn A Hartley, Michael J Flynn, John P Bingham, et al.
Bioconjugate Chemistry|September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition ChemistryMichael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug ConjugatesMary Jane Masson Hinrichs, Pauline M Ryan, Bo Zheng, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Chemical Communications (Cambridge, England)|August 29, 2002
Synthesis of novel C2-aryl pyrrolobenzodiazepines (PBDs) as potential antitumour agentsNectaroula Cooper, David R Hagan, Arnaud Tiberghien, et al.
Chemical Communications (Cambridge, England)|February 1, 2023
Peroxide-cleavable linkers for antibody-drug conjugatesNicola Ashman, Jonathan D Bargh, Stephen J Walsh, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|February 4, 2026
Bismuth BicyclesSaan Voss, Amin Sagar, Arnaud Tiberghien, et al.
Bioconjugate Chemistry|March 27, 2019
Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life ExtensionQing Li, Allison Barrett, Balakumar Vijayakrishnan, et al.
Blood|January 5, 2018
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignanciesFrancesca Zammarchi, Simon Corbett, Lauren Adams, et al.
Journal of Medicinal Chemistry|September 1, 2006
Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugatesGeoff Wells, Christopher R H Martin, Philip W Howard, et al.
Plos Neglected Tropical Diseases|May 24, 2019
A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasisPaula MacGregor, Andrea L Gonzalez-Munoz, Fatoumatta Jobe, et al.
Scientific Reports|July 12, 2018
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirineJohn A Hartley, Michael J Flynn, John P Bingham, et al.
Bioconjugate Chemistry|September 3, 2015
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition ChemistryMichael P VanBrunt, Kurt Shanebeck, Zachary Caldwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 21, 2017
Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug ConjugatesMary Jane Masson Hinrichs, Pauline M Ryan, Bo Zheng, et al.
Pageof 2